- Home
- MANH vs FMS Comparison
MANH vs FMS Comparison
Compare MANH & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MANH
- FMS
- Stock Information
- Founded
- MANH 1990
- FMS 1996
- Country
- MANH United States
- FMS Germany
- Employees
- MANH N/A
- FMS N/A
- Industry
- MANH Computer Software: Prepackaged Software
- FMS Misc Health and Biotechnology Services
- Sector
- MANH Technology
- FMS Health Care
- Exchange
- MANH Nasdaq
- FMS Nasdaq
- Market Cap
- MANH 13.0B
- FMS 15.0B
- IPO Year
- MANH 1998
- FMS 1996
- Fundamental
- Price
- MANH $196.81
- FMS $26.79
- Analyst Decision
- MANH Buy
- FMS Sell
- Analyst Count
- MANH 11
- FMS 2
- Target Price
- MANH $226.70
- FMS $30.00
- AVG Volume (30 Days)
- MANH 485.1K
- FMS 335.7K
- Earning Date
- MANH 10-21-2025
- FMS 11-04-2025
- Dividend Yield
- MANH N/A
- FMS 2.13%
- EPS Growth
- MANH 9.17
- FMS 23.39
- EPS
- MANH 3.58
- FMS 2.62
- Revenue
- MANH $1,057,690,000.00
- FMS $22,922,038,756.00
- Revenue This Year
- MANH $5.15
- FMS $1.83
- Revenue Next Year
- MANH $6.66
- FMS $3.27
- P/E Ratio
- MANH $55.11
- FMS $20.32
- Revenue Growth
- MANH 6.13
- FMS 0.53
- 52 Week Low
- MANH $140.81
- FMS $18.94
- 52 Week High
- MANH $312.60
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- MANH 38.19
- FMS 61.40
- Support Level
- MANH $196.00
- FMS $26.52
- Resistance Level
- MANH $209.86
- FMS $27.64
- Average True Range (ATR)
- MANH 5.13
- FMS 0.37
- MACD
- MANH -0.87
- FMS 0.11
- Stochastic Oscillator
- MANH 2.35
- FMS 67.18
About MANH Manhattan Associates Inc.
Manhattan Associates provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers around the world.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.